Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CNI Transient Replacement by Belatacept From 3 to 12 Months Post Transplantation in Patients With Early Graft Dysfunction

NCT04013620 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT04013620
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04013620 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CNI Transient Replacement by Belatacept From 3 to 12 Months Post Transplantation in Patients With Early Graft Dysfunction
Lead sponsor
Nantes University Hospital
Phase
Phase 3
Overall status
Unknown status
Start date
September 1, 2020
Completion date
July 9, 2022
Enrollment
48 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney failure